• Ms. Snnehaa Bhosle
• Dr. Pranati Tilak
• Dr. Meera Deshmukh
• Mr. Shubham Gore

Cancer is characterized by abnormalities in mechanisms that regulate cell cycle, leading to the survival and proliferation of malignant cancer cells. The advent of nanotechnology has revolutionized the arena of cancer diagnosis and its treatment. Nanoparticles ranging (1-100nm) are used in the treatment of cancer owing to their specific advantages includes biocompatibility, reduced toxicity, excellent stability, enhanced permeability retention, and precise targeting. Due to these factors, they are being investigated more vigorously in multidrug resistance mechanisms. This review summarizes novel and emerging nanoparticles fabricated in research and clinical use, discusses current limitations and obstacles that hinder the translation from research to clinical use, and provides suggestions for more efficient adoption of nanomaterials in cancer therapy.

Nanoparticles, multidrug resistance mechanisms, nanotechnology

"A COMPREHENSIVE REVIEW: NANOPARTICLES AND ITS TYPES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 3, page no.a758-a766, March-2023, Available :http://www.jetir.org/papers/JETIR2303092.pdf

"A COMPREHENSIVE REVIEW: NANOPARTICLES AND ITS TYPES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 3, page no. ppa758-a766, March-2023, Available at : http://www.jetir.org/papers/JETIR2303092.pdf